Benchling helps Xilio Therapeutics see complex lessons in their data

Xilio Therapeutics is committed to transforming cancer treatment by unleashing the full power of highly potent immunotherapies in tumors. As the company grows and scales, however, sharing and accessing valuable data can become a challenge.
In this video, you’ll learn how Xilio Therapeutics sustained their impact by using Benchling to:
  • Store data in a more uniform and structured way 

  • Simplify naming, linking, and editing of sequences

  • Extend easier access to data within and across teams

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image